{"text_format":"3","workbook":"xlsx","n_sheets":12,"sheets":["EXPORT","impression (voulu)","impression","ACTIVITÉS D'ÉVALUATION","ACTIVITÉS ÉDITORIALES","ACTIVITÉS PÉDAGOGIQUES","AUTRES ACTIVITÉS SCIENTIFIQUES","BREVETS","CONTRATS","ESSAIS CLINIQUES","PRODUCTION","SEMINAIRES"],"not_rendered":{"images":15,"macros":1,"defined_names":10},"read":"whole","date_system":"1900"}

{"sheet":"EXPORT","index":0,"n_rows":2,"n_cols":1,"rows_kept":2}
[]
["Sélection de l'équipe à exporter :"]

{"sheet":"impression (voulu)","index":1,"n_rows":13,"n_cols":1,"rows_kept":13,"merged":[[4,0,5,6],[6,0,9,6],[10,0,11,6],[12,0,13,6]]}
["(Ce que je souhaite avoir comme résultats :)"]
[]
["Pour l'équipe n°1 :"]
["Il a été rédigé 4 activité(s) d'évaluation :"]
["- Natation Nathalie de l'Équipe 03 a participé(e) à un(e) Comité pour Immunology, le 43572, pour le laboratoire LaboSympaN5, concernant l'article ArticleBofBof5 de la revue Immunology."]
[]
["- Volley Anne de l'Équipe 03 a participé(e) à un(e) Reviewing pour mekalonomoiaubrg, le 43766, pour le laboratoire LaboSympaN6, concernant l'article ArticleBofBof6 de la revue mekalonomoiaubrg. Cette personne a eu une responsabilité d'évaluation pour MIT, projet avec Dr Mertcuy."]
[]
[]
[]
["- Handball François de l'Équipe 03  a participé(e) à un(e) Comité pour Search On Plevra, le 43510, pour le laboratoire LaboSympaN7, concernant l'article ArticleBofBof7 de la revue Search."]
[]
["- Tennis Armelle de l'Équipe 03  a participé(e) à un(e) Reviewing pour Informal, le 43589, pour le laboratoire LaboSympaN8, concernant l'article ArticleBofBof8 de la revue Informatic Science."]

{"sheet":"impression","index":2,"n_rows":3,"n_cols":3,"rows_kept":3}
[]
["Pour l'équipe","XX"]
["Il a été rédigé ",11,"activité(s) d'évaluation :"]

{"sheet":"ACTIVITÉS D'ÉVALUATION","index":3,"n_rows":11,"n_cols":12,"rows_kept":11}
[]
[]
["Nom de l'evaluateur","Prenom de l'evaluateur","Equipe de l'evaluateur","Nature de l'activité","Nom du projet évalué","Date de l'évaluation","Nom du labo évalué","Nom de l'article évalué","Nom de la revue","Résponsabilité dans l'instance d'évaluation","Nom de l'instance","Précisions ?"]
["Golf","Emmanuel","Équipe 01 ","Reviewing","Blood","2019-04-09","LaboSympaN1","ArticleBofBof1","Blood","Non"]
["Foot","Henri","Équipe 01","Relecture","Science","2019-10-09","LaboSympaN2","ArticleBofBof2","Science","Oui","CNRS","Nobel"]
["Basket","Brigitte","Équipe 02","Projet de recherche","Cells","2019-11-25","LaboSympaN3","ArticleBofBof3","Cells","Non"]
["Polo","Gérard","Équipe 02","Évaluation de laboratoire","Cancero","2019-04-28","LaboSympaN4","ArticleBofBof4","Cancero","Non"]
["Natation","Nathalie","Équipe 03","Comité","Immunology","2019-04-17","LaboSympaN5","ArticleBofBof5","Immunology","Non"]
["Volley","Anne","Équipe 03","Reviewing","mekalonomoiaubrg","2019-10-28","LaboSympaN6","ArticleBofBof6","mekalonomoiaubrg","Oui","MIT","projet avec Dr Mertcuy"]
["Handball","François","Équipe 03 ","Comité","Search On Plevra","2019-02-14","LaboSympaN7","ArticleBofBof7","Search","Non"]
["Tennis","Armelle","Équipe 03 ","Reviewing","Informal","2019-05-04","LaboSympaN8","ArticleBofBof8","Informatic Science","Non"]

{"sheet":"ACTIVITÉS ÉDITORIALES","index":4,"n_rows":11,"n_cols":9,"rows_kept":11}
[]
[]
["Nom","Prenom","Equipe","Forme activite editoriales","TitreRevue","Date","Direction de collection","Titre de collection","Periodicite"]
["Golf","Emmanuel","Équipe 01","Revue","Blood","2019-04-09","Oui","Cells on Immuno","Trimestrielle"]
["Foot","Henri","Équipe 01","Journal scientifique","Science","2019-10-09","Non",null,"Mensuelle"]
["Basket","Brigitte","Équipe 02","Collection","Cells","2019-11-25","Non",null,"Bi-Mensuelle"]
["Polo","Gérard","Équipe 02","Revue","Cancero","2019-04-28","Non",null,"Mensuelle"]
["Natation","Nathalie","Équipe 03","Journal scientifique","Immunology","2019-04-17","Non",null,"Mensuelle"]
["Volley","Anne","Équipe 03","Revue","mekalonomoiaubrg","2019-10-28","Non",null,"Trimestrielle"]
["Handball","François","Équipe 03 ","Collection","Search On Plevra","2019-02-14","Oui","Nucleo Cells on demand ","Bi-Mensuelle"]
["Tennis","Armelle","Équipe 03 ","Revue","Informal","2019-05-04","Non",null,"Trimestrielle"]

{"sheet":"ACTIVITÉS PÉDAGOGIQUES","index":5,"n_rows":11,"n_cols":7,"rows_kept":11}
[]
[]
["Forme de l'activité (EXCEL)","Titre de l'activité","Date de l'activité","Nom Auteur de l'activité ","Prenom Auteur de l'activité ","Num Eq de l'activité","Commentaires"]
["Ouvrage","Reviewing","2019-10-25","Golf","Emmanuel","Équipe 01"]
["MOOC","Relecture","2019-02-27","Foot","Henri","Équipe 01","Activité très demandée sur ce type de cellules et extremement valorisante, à continuer absolument !"]
["e-learning","Projet de recherche","2019-11-10","Basket","Brigitte","Équipe 02"]
["Action de vulgarisation grand public","Évaluation de laboratoire","2019-10-12","Polo","Gérard","Équipe 02"]
["Ouvrage","Comité","2019-05-12","Natation","Nathalie","Équipe 03"]
["MOOC","Reviewing","2019-12-28","Volley","Anne","Équipe 03","Oui"]
["e-learning","Évaluation de laboratoire","2019-02-14","Handball","François","Équipe 03 "]
["MOOC","Comité","2019-05-04","Tennis","Armelle","Équipe 03 "]

{"sheet":"AUTRES ACTIVITÉS SCIENTIFIQUES","index":6,"n_rows":8,"n_cols":7,"rows_kept":8}
[]
[]
["Forme de l'activité (EXCEL)","Nom ","Nom createur/trice","Prenom createur/trice","Equipe createur/trice","Portée","Date"]
["BDD","BDD1","Golf","Emmanuel","Équipe 01","Européenne","2019-10-25"]
["Cohorte","Cohorte1","Basket","Brigitte","Équipe 02","Régionale","2019-02-27"]
["Logiciel","Logiciel1","Natation","Nathalie","Équipe 03","Nationale","2019-11-10"]
["Logiciel","Logiciel2","Handball","François","Équipe 03 ","Locale","2019-02-14"]
["Logiciel","Logiciel3","Tennis","Armelle","Équipe 03 ","Internationale","2019-05-04"]

{"sheet":"BREVETS","index":7,"n_rows":8,"n_cols":7,"rows_kept":8}
[]
[]
["Date de brevet","Référence Brevet","Titre de Brevet","Nom inventeur Brevet","Prenom inventeur du Brevet","Num Eq du porteur","Niveau du brevet"]
["2019-08-18","QVY/IFYC2020/063848","BrevetTopMoumoute1","Golf, Polo, Volley, Futsalle","Emmanuel, Philippe, Edouard, Stéphane","Équipe 01","Déclaration d'intention"]
["2019-01-22","QVY/IFYC2020/063849","BrevetTopMoumoute2","Basket","Brigitte","Équipe 02","Brevet déposé"]
["2019-11-18","QVY/IFYC2020/063850","BrevetTopMoumoute3","Natation","Nathalie","Équipe 03","Brevet accepté"]
["2019-02-14","QVY/IFYC2020/063851","BrevetTopMoumoute4","Handball","François","Équipe 03 ","Brevet licencié"]
["2019-05-04","QVY/IFYC2020/063852","BrevetTopMoumoute5","Tennis","Armelle","Équipe 03 ","Brevet déposé"]

{"sheet":"CONTRATS","index":8,"n_rows":8,"n_cols":9,"rows_kept":8}
[]
[]
["Date de début de contrat","Date de fin de contrat","Origine du contrat","Titre du projet","Nom du porteur","Prenom du porteur","Num Eq du porteur","Montant du contrat","Durée du contrat"]
["2019-01-24","2021-01-24","ANR","GrosContrat1","Golf","Emmanuel","Équipe 01",{"v":6000,"d":"6,000.00 €"},2]
["2019-12-17","2024-12-17","Union Européenne","GrosContrat2","Basket","Brigitte","Équipe 02",{"v":500,"d":"500.00 €"},5]
["2019-12-21","2021-12-21","ANR","GrosContrat3","Natation","Nathalie","Équipe 03",{"v":7200,"d":"7,200.00 €"},2]
["2019-02-14","2021-02-14","SFR Health","GrosContrat4","Handball","François","Équipe 03 ",{"v":1890,"d":"1,890.00 €"},2]
["2019-05-04","2023-05-04","NEXT","GrosContrat5","Tennis","Armelle","Équipe 03 ",{"v":4900,"d":"4,900.00 €"},4]

{"sheet":"ESSAIS CLINIQUES","index":9,"n_rows":11,"n_cols":8,"rows_kept":11}
[]
[]
["Titre de l'essai","sous titre de l'essai","Phase essai","Nom du porteur de l'essai","Prénom du porteur de l'essai","Num Eq de l'evaluateur","Partenaire de l'essai","Date de l'essai"]
["Vaccination by Autologous for Myelogenous Patients in Second Complete Remission ","Cells vaccinations are increasingly used in order to develop antitumoral immune response. This will be a Phase 2 trial using autologous in acute myelogenous patients in second Complete remission (CR).","Phase II","Golf","Emmanuel","Équipe 01","LaboSympaN1","2019-07-20"]
["A Trial of ObiKUTYCzumab,DYE-19899 Minus Itrocurus in Relapsed Mantle Cell Plekotovroma Patients","Dose fic and escalation, phase I/II study.\n\nThis study will be driven into 2 steps. The first will be to saving the health of the combination of ObiKUTYCzumab and Itrocurus at fixed doses in patients with relapsed Mantle Cell Plekotrovroma.\n\nA total of 59 patients will be included in this first step with grouped inclusions of 4 patients (a safety evaluation will be performed at each inclusion of 4 patients).\n\nThe second step  will be conducted if no unacceptable toxicity is observed during the first step and 135 new patients will be included. The aim of the second step is to determine the IYDC of the DYE-19899.","Phase III","Foot","Henri","Équipe 01","LaboSympaN2","2019-10-21"]
["Dose-escalation Study of Oral Administration of TDR-194 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma","The purpose of this study is to determine the safety profile and tolerability of TDR-194 in patients with CLL, B-Cell NHL and MM, in terms of Dose-Limiting Toxicities (DLTs), Maximum Tolerated Dose (MTD) and determine the Recommended Phase 2 Dose (RP2D) through safety profile (DLT, MTD), PK profile, PD profile and preliminary efficacy.","Phase I","Basket","Brigitte","Équipe 02","LaboSympaN3","2019-03-12"]
["Adoptive Transfer of Specific Melanoma Antigens ZPOV-1 Y Cells in Metastatic Melanocartoma Patients: a Phase I/II Study (MelSort)","This study evaluates the safety as well as the potential clinical efficacy of an adoptive transfer of CD8+ T cells, sorted with HLA-peptide multimers and specific for Melan-A and MELOE-1 melanocartomaantigens, to patients suffering from advanced metastatic Melanocartoma (stages IIIc and IV).","Phase II","Polo","Gérard","Équipe 02","LaboSympaN4","2019-10-11"]
["CLINICAL PHASE 3 STUDY TO MONITOR THE SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (UMOBOLIZERYK®) ADMINISTERED AT MODIFIED DOSING REGIMENS IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES",null,"Phase III","Natation","Nathalie","Équipe 03","LaboSympaN5","2019-08-08"]
["Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer","This trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer. Treatments for cancer can cause a problem to the nervous system (called peripheral neuropathy) that can lead to tingling or less feeling in hands and feet. Studying certain risk factors, such as age, gender, pre-existing conditions, and the type of treatment for cancer may help doctors estimate how likely patients are to develop the nerve disorder.","Phase IV","Volley","Anne","Équipe 03","LaboSympaN6","2019-03-02"]
["Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference (NPV-MRI-02)","To evaluate the negative predictive value of mpMRI in the detection of prostate cancer using cystoprostatectomy specimen as the reference","Phase III","Handball","François","Équipe 03 ","LaboSympaN7","2019-02-14"]
["Effectiveness of Custom-made Foot Orthoses vs Heel Lifts in Children With Calcaneal Apophysitis","The study was a parallel-group, randomized controlled trial with concealed allocation, blinding of investigators and assessors and intention-to-treat analysis. It examined the effect of custom-made foot orthoses and heel lifts in children with calcaneal apophysitis.","Phase IV","Tennis","Armelle","Équipe 03 ","LaboSympaN8","2019-05-04"]

{"sheet":"PRODUCTION","index":10,"n_rows":8,"n_cols":11,"rows_kept":8}
[]
[]
["FormeProduction","TitreProduction","NomAuteur","PrenomAuteur","NumEqSem","NomCoAuteur","PrenomCoAuteur","NomManifestation","VilleManifestation","PaysLabo","Date Manifestation"]
["poster","blablabla1","Golf","Emmanuel","Équipe 01","Polo, Volley, Futsalle","Laura, Sandrine, Mickael","ManifestationSuperCool1","Washington","USA","2019-04-23"]
["Communication avec actes","blablabla2","Basket","Brigitte","Équipe 02",null,null,"ManifestationSuperCool2","Paris","France","2019-06-08"]
["communication sans actes","blablabla3","Natation","Nathalie","Équipe 03",null,null,"ManifestationSuperCool3","Taiwan","Taiwan","2019-09-18"]
["poster","blablabla4","Handball","François","Équipe 03 ",null,null,"ManifestationSuperCool4","Montpellier","France","2019-02-14"]
["communication sans actes","blablabla5","Tennis","Armelle","Équipe 03 ","Hockey, Baseball, Rugby","Vincent, Julie, David","ManifestationSuperCool5","Abidjan","Cote d'Ivoire","2019-05-04"]

{"sheet":"SEMINAIRES","index":11,"n_rows":11,"n_cols":9,"rows_kept":11}
[]
[]
["NomIntervenant","PrenomIntervenant","InterneExterne","NomLabo","VilleLabo","PaysLabo","DateSeminaire","Titre Séminaire","NumEqSem"]
["Golf","Emmanuel","Interne","Pasteur Paris","Paris","France","2019-11-20","blablabla1-1","Équipe 01"]
["Foot","Henri","Externe","U8464","Lyon","France","2019-11-29","blablabla2-1","Équipe 01"]
["Basket","Brigitte","Interne","Curie Séoul","Séoul","Corée du Sud","2019-12-25","blablabla1-2","Équipe 02"]
["Polo","Gérard","Externe","Lab etranger 2","Manchester","Angleterre","2019-05-29","blablabla2-2","Équipe 02"]
["Natation","Nathalie","Interne","U1564","Nantes","France","2019-09-24","blablabla1-3","Équipe 03"]
["Volley","Anne","Externe","U8464","Strasbourg","France","2019-01-10","blablabla2-3","Équipe 03"]
["Handball","François","Interne","U1564","Marseille","France","2019-02-14","blablabla3-3","Équipe 03 "]
["Tennis","Armelle","Interne","U1564","Athène","Grece","2019-05-04","blablabla4-3","Équipe 03 "]